Evidence-Based Medical News

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Radiology & Imaging Genetics & Precision Medicine Pulmonology & Critical Care Anesthesiology & Pain Medicine Nephrology Emergency Medicine Physical Medicine & Rehab Urology Hematology Ophthalmology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Text Size

Log in / Sign up

brexpiprazole

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of brexpiprazole

37 trials tracked of brexpiprazole: 33 in phase 3 or 4 and 20 with published results. The most-cited published study has 91 citations.

37Trials tracked

33Phase 3 & 4

0Recruiting

20With published results

Phase distribution

Phase 4 4 Phase 3 29 Phase 2 3 Phase 1 1

Phase 3 Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia Completed · 91 cited
Phase 3 Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment Completed · 23 cited
Phase 3 Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms Completed · 23 cited
Phase 3 A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial Completed · 20 cited
Phase 3 Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity Completed · 16 cited
Phase 3 A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type Completed · 14 cited

Show 31 more trials

Phase 3 Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD Completed · 13 cited
Phase 3 Brexpiprazole in Patients With Schizophrenia Completed · 10 cited
Phase 3 Brexpiprazole in Patients With Acute Schizophrenia Completed · 10 cited
Phase 3 Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia Completed · 10 cited
Phase 4 Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder Completed · 7 cited
Phase 3 A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder Completed · 3 cited
Phase 3 Brexpiprazole for the Long-term Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type Completed · 3 cited
Phase 4 Brexpiprazole for Bipolar Depression Completed · 2 cited
Phase 3 A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type Completed · 2 cited
Phase 3 A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder Completed · 2 cited
Phase 3 Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD) Completed · 2 cited
Phase 4 Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder Completed · 1 cited
Phase 3 Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type Completed · 1 cited
Phase 3 Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder Completed
Phase 4 A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) Completed
Phase 3 Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Early-Episode Schizophrenia Completed
Phase 3 Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment Completed
Phase 3 A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder Completed
Phase 3 A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder Completed
Phase 3 A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder. Completed
Phase 3 Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148 Completed
Phase 3 A Study of Brexpiprazole in Patients With Major Depressive Disorder Completed
Phase 3 Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder Completed
Phase 3 Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy Completed
Phase 3 Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder Completed
Phase 3 Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy Completed
Phase 3 Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Acute Schizophrenia Completed
Phase 2 A Study of Flexible Dose Brexpiprazole as Monotherapy or Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder (PTSD) Completed
Phase 2 A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder Completed
Phase 2 A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication Completed
Phase 1 Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder Completed

Showing the 37 most-cited and recently-updated of 37 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.